| Bid Price | 10.00p | High Price | 11.50p |
|---|
| Ask Price | 11.00p | Low Price | 10.22p |
|---|
| Open Price | 11.00p | Spread | 9.09% |
|---|
| Prev Close | 11.00p | Volume | 1,884,780 |
|---|
Fusion Antibodies PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Aug 4, 2025 | 11.00 | 11.50 | 10.22 | 10.50 | 1,884,780 |
| Aug 1, 2025 | 10.25 | 11.50 | 9.20 | 11.00 | 1,587,980 |
| Jul 31, 2025 | 10.50 | 11.00 | 10.00 | 10.25 | 751,527 |
| Jul 30, 2025 | 10.00 | 11.50 | 10.00 | 10.50 | 1,623,459 |
| Jul 29, 2025 | 9.75 | 11.00 | 9.50 | 10.00 | 2,806,762 |
Fusion Antibodies PLC Information
| Name | Fusion Antibodies PLC | Index | FTSE AIM All Share |
|---|
| ISIN | GB00BDQZGK16 | Epic | FAB |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 30,000 | Trading Status | Closed |
|---|
| Shares in Issue | 113.66 m | Prev Close | 11.00p |
|---|
| PE Ratio | | Market Cap | £11.93 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | -£0.01 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | -0.519244 | DPS Growth (%) | 0 |
|---|
| Current Ratio | 3.252273 | Quick Ratio | 2.729545 |
|---|
Fusion Antibodies PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 11/07/25 | TIN | Colin Walsh | NED | 211,618 @ £0.00 | £0.00 |
| 11/07/25 | TIN | Colin Walsh | NED | 58,271 @ £0.00 | £0.00 |
| 12/05/25 | LOF | Colin Walsh | NED | 221,311 @ £0.06 | £13,500.00 |
| 12/05/25 | LOF | Simon Douglas | CH | 61,475 @ £0.06 | £3,750.00 |
| 12/05/25 | LOF | Matthew Baker | NED | 55,327 @ £0.06 | £3,375.00 |
| 06/05/25 | BUY | Adrian Kinkaid | CEO | 100,000 @ £0.06 | £6,180.00 |
| 22/10/24 | LOF | Colin Walsh | NED | 325,301 @ £0.04 | £13,500.00 |
| 22/10/24 | LOF | Simon Douglas | CH | 180,722 @ £0.04 | £7,500.00 |
| 22/10/24 | LOF | Matthew Baker | NED | 81,325 @ £0.04 | £3,375.00 |
| 16/10/24 | BUY | Adrian Kinkaid | CEO | 83,728 @ £0.04 | £3,504.00 |
Fusion Antibodies PLC News
